All the news Showing 10 of 10 articles from: EASL 2017Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Treatment for previous non-responders & relapsers Merck Announces New Phase 2 Data on Investigational Triple Combination Therapy MK-3682B for Chronic Hepatitis C Merck press release / 24 April 2017 Treatment and HCV genotype Shortened duration triple therapy fails in genotype 3 HCV Healio Hepatology / 24 April 2017 Epidemiology One-third of UK adolescents with HCV developed serious liver disease Healio Hepatology / 22 April 2017 International policy WHO's Global Hepatitis Report sets baseline to eliminate viral hepatitis by 2030 World Hepatitis Alliance / 21 April 2017 Epidemiology New hepatitis data highlight need for urgent global response World Health Organization / 21 April 2017 Access to medicines & diagnostics The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir Medicines Patent Pool / 21 April 2017 National policy Global HCV elimination requires changes in prescribing, access, policy Healio Hepatology / 21 April 2017 Fibrosis NASH: It's Fibrosis, Not Fat, that Matters MedPage Today Gastroenterology / 21 April 2017 Disease course and symptoms Fecal microbiota transplants improve cognitive impairment caused by severe liver disease EASL / 21 April 2017 Hepatocellular carcinoma (HCC) Nivolumab produces durable responses & long-term survival in severe liver cancer patients Eurekalert Inf Dis / 21 April 2017 ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive